NIDA

Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Ozempic, Wegovy Lowers Risk Of Cannabis Use Disorder Says New Study
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Ozempic, Wegovy Lowers Risk Of Cannabis Use Disorder Says New Study
Canadian Teens Find Cannabis Harder To Get Post-Legalization, Study Finds
The Kids Are Alright: Government Study Finds Teen Cannabis Use Holds Steady Despite Increased State Legalization

NIDA Recent News

Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
With more and more states and countries embracing cannabis whether for medical or recreational purposes, it could be assumed that the number of people dependent on it would also increase.
Why Are Cannabis Users Often Lean Despite The Munchies? Science May Have The Answer
Researchers in California have come up with a scientific explanation as to why cannabis users tend to be thinner and less diabetes-prone despite the munchies. The new facts should be a cautionary tale for teenagers to hold off before lighting up. 
Federal Psychedelics Reform Has More Lobbyists, Addiction Research Grant & Upcoming $27M VA Report
As several states advance measures relating to the lawful use of psychedelic medicines and with Congressmembers aiming to do their part at the federal level, a key sign could anticipate further movement in Washington D.C. </
NIDA Director Nora Volkow Calls Regulating Cannabis 'Crucial' As More States Legalize It
Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that regulating cannabis products is "crucial," to address the pace of states' adoption of both medical and recreational use of cannabis.
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction.
NIDA Study Finds Young Men At Higher Risk Of Schizophrenia Linked With Cannabis Use Disorder
Young men with cannabis use disorder, or excessive dependency on marijuana consumption, are at higher risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of Denmark and the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. 
Top FDA Official Says Marijuana Scheduling Review Is 'A Very High Priority,' But Who Has Final Say?
Department of Health and Human Services (HHS) Secretary Xavier Becerra said earlier this month that the agency plans to review the status of cannabis as a Schedule I drug following President Joe
More Adults, Fewer Teens, Are Using Psychedelics, Columbia University Study Finds
Ongoing discussions on whether psychedelics can help treat mental health conditions and improve quality of life have compelled officials and researchers to seek public opinion.
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
This week, an annual drug use survey Monitoring the Future (MTF), conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor 
Psychedelics And The National Institutes Of Health—How Do They Relate?
As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel
National Institute On Drug Abuse Seeks To Set Up Medical Marijuana Registry, Here's How It Will Function
The National Institute on Drug Abuse (NIDA) announced recently that it was searching for new partners to supply cannabis for research purposes.
New Study Finds Marijuana Research Has Increased Despite Prohibition
A new study, recently published in the Journal of Cannabis Research reported that the number of cannabis publications continued to increase during the last two decades despite cannabis prohibition.
What 2021 Taught Us About Youth Cannabis Use
Cannabis' possible effects on young people will continue to be of the utmost concern as the legal marketplace takes shape. Throughout 2021, several studies helped further comprehension of an area that still suffers from a significant education gap. While nothing became definitive in 2021, research helped advance understanding for several critical areas.
Study: Marijuana Use Among College-Age Adults Hit Historic High In 2020, Alcohol Use Declines
Marijuana use continued to rise among college students and same-aged peers who are not in college in 2020, according to survey results from the 2020 Monitoring the Future (MTF) panel study, reported by the National Institute on Drug Abuse (NIDA). 
'Psyched': Compass Closes $80M Series B, Danish Scientists Discover Method For Producing Psilocybin From Yeast
Welcome to Psyched, a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry.
Lawsuit Pushes DEA To Explain Delays As Applications For Marijuana Research Pile Up
For years, the Drug Enforcement Administration has delayed applications for growing and researching marijuana without explanation.  No more. A new lawsuit has pushed the enforcement agency into publishing an internal memo that explains why it has yet to hand out more licenses for the production of research-grade marijuana.
House Committee Holds Hearing On 'Cannabis Policies for the New Decade'
National Institute For Drug Abuse Issues Grant Call For Cannabis Research